5/16
06:22 am
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
5/16
06:22 am
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Low
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
5/14
08:07 am
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $175.00 price target on the stock.
Low
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $175.00 price target on the stock.
5/14
08:07 am
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $175.00 price target on the stock.
Low
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $175.00 price target on the stock.
5/14
05:15 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
5/3
06:00 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
5/3
06:00 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
5/2
03:18 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
5/2
02:22 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
5/2
02:22 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
5/2
01:59 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
5/2
01:59 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
5/2
10:24 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
5/2
10:24 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
5/2
08:55 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
5/2
08:55 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
5/2
05:41 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
5/2
05:41 am
nbix
Rating for NBIX
Medium
Report
Rating for NBIX
5/1
12:34 pm
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
5/1
11:47 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
5/1
11:47 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
4/24
10:12 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
4/24
10:12 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
4/24
08:10 am
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $150.00 price target on the stock.
Low
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $150.00 price target on the stock.
4/24
08:10 am
nbix
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $200.00 price target on the stock.
Low
Report
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $200.00 price target on the stock.